サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1760507

風邪、アレルギー、副鼻腔炎用錠剤の世界市場レポート 2025年

Cold Allergy And Sinus Tablet Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
風邪、アレルギー、副鼻腔炎用錠剤の世界市場レポート 2025年
出版日: 2025年07月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

風邪、アレルギー、副鼻腔炎用錠剤の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.3％で376億9,000万米ドルに成長します。予測期間中の成長は、大気汚染レベルの上昇、都市化の進展、高齢者人口の増加、眠くならない製剤への需要の高まり、呼吸器系疾患の増加などが牽引するとみられます。予測期間中に予想される主な動向としては、自然療法やハーブ療法へのシフト、併用療法への嗜好の高まり、個別化されたアレルギー治療、鼻腔ドラッグデリバリーシステムの革新、小児に優しい製剤の重視などが挙げられます。

アレルギーおよび呼吸器疾患の発生率の増加が、今後数年間における風邪、アレルギー、副鼻腔炎用錠剤市場の成長を牽引すると予測されます。これらの疾患は、アレルゲンに対する免疫系の反応を伴い、呼吸器系に影響を及ぼし、喘息やアレルギー性鼻炎などの病気を引き起こします。アレルギーや呼吸器系の問題の急増は、免疫や呼吸器系に有害な反応を引き起こすアレルゲンや空気中の刺激物への曝露を高める大気汚染の増加に大きく関係しています。風邪、アレルギー、副鼻腔用錠剤は、効果的な症状緩和を提供することでこれらの症状の管理を支援し、風邪、副鼻腔感染症、アレルギー反応に苦しむ人々の生活の質を向上させます。例えば、2023年9月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、慢性呼吸器疾患が410万人の死亡の原因となっており、心血管疾患（1,790万人死亡）、がん（930万人死亡）に次いで、糖尿病（200万人死亡）を上回っていると報告しました。このように、呼吸器疾患やアレルギー疾患の有病率の上昇が、風邪、アレルギー、副鼻腔炎用錠剤市場の需要を促進しています。

風邪、アレルギー、副鼻腔炎用錠剤分野の主要企業は、長期間の症状緩和とユーザーの利便性向上のため、徐放性錠剤などの高度な製剤に投資しています。徐放性錠剤は、治療効果を持続させるために、薬物を長時間にわたって徐々に放出するように設計されています。例えば、2022年7月、インドに本社を置く製薬会社Dr. Reddy's Laboratories Ltd.は、店頭販売（OTC）版のAllegra-D 24 HRを米国で発売しました。この製剤は、180mgのフェキソフェナジン塩酸塩と240mgのプソイドエフェドリン塩酸塩を配合した徐放性製剤で、副鼻腔圧、鼻づまり、くしゃみを24時間緩和します。この製品は、季節性アレルギー性鼻炎および同様の症状に関連する症状を管理するための、費用対効果が高く、眠くならない選択肢を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の風邪、アレルギー、副鼻腔炎用錠剤のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：成長率分析
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場の実績：規模と成長、2019～2024年
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場の予測：規模と成長、2024～2029年、2034年
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 抗ヒスタミン薬
  • 鼻づまり解消薬
  • 咳止め薬
  • 去痰薬
  • 配合錠
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：処方タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 錠剤
  • カプセル
  • 液体
  • 発泡錠
  • 粉末
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：消費者年齢層別、実績と予測、2019～2024年、2024～2029年、2034年
  • 子供（0～12歳）
  • ティーンエイジャー（13～19歳）
  • 成人（20～64歳）
  • 高齢者（65歳以上）
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
  • アレルギー性鼻炎
  • 風邪
  • 副鼻腔炎
  • その他
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
  • 薬局
  • オンラインストア
  • スーパーマーケットまたはハイパーマーケット
  • その他
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：抗ヒスタミン薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • ロラタジン
  • セチリジン
  • フェキソフェナジン
  • ジフェンヒドラミン
  • クロルフェニラミン
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：鼻づまり解消薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • プソイドエフェドリン
  • フェニレフリン
  • オキシメタゾリン
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：咳止め薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • デキストロメトルファン
  • コデイン
  • ベンゾナテート
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：去痰薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • グアイフェネシン
  • 塩化アンモニウム
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：配合錠のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 抗ヒスタミン薬・鼻づまり解消薬配合
  • 抗ヒスタミン薬・咳止め薬配合
  • 多症状風邪・インフルエンザ錠

第7章 地域別・国別分析

  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界の風邪、アレルギー、副鼻腔炎用錠剤市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 風邪、アレルギー、副鼻腔炎用錠剤市場：競合情勢
  • 風邪、アレルギー、副鼻腔炎用錠剤市場：企業プロファイル
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline plc
  • Reckitt Benckiser Group plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Sandoz Group AG
  • Alcon Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Dr. Reddy's Laboratories
  • Cipla Limited
  • Hikma Pharmaceuticals plc
  • Lupin Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • LETI Pharma GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 風邪、アレルギー、副鼻腔炎用錠剤市場2029年：新たな機会を提供する国
  • 風邪、アレルギー、副鼻腔炎用錠剤市場2029年：新たな機会を提供するセグメント
  • 風邪、アレルギー、副鼻腔炎用錠剤市場2029年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35384

Cold allergy and sinus tablets are over-the-counter or prescription medications formulated to relieve symptoms related to colds, allergies, and sinus conditions. These tablets typically combine antihistamines, decongestants, and pain relievers to reduce inflammation, congestion, and discomfort caused by these conditions.

The main types of cold allergy and sinus tablets include antihistamines, decongestants, cough suppressants, expectorants, and combination tablets. Antihistamines are medications that block or reduce the effects of histamines, chemicals released by the immune system during allergic reactions. These products are available in various formulations, including tablets, capsules, liquids, effervescent tablets, and powders. The consumer age groups vary from children (0-12 years) to teenagers (13-19 years), adults (20-64 years), and seniors (65 years and above). These products address multiple conditions, such as allergic rhinitis, the common cold, sinusitis, and more. Distribution occurs through several channels, including pharmacies, online stores, supermarkets or hypermarkets, and others.

The cold allergy and sinus tablet market research report is one of a series of new reports from The Business Research Company that provides cold allergy and sinus tablet market statistics, including the cold allergy and sinus tablet industry global market size, regional shares, competitors with the cold allergy and sinus tablet market share, detailed cold allergy and sinus tablet market segments, market trends, and opportunities, and any further data you may need to thrive in the cold allergy and sinus tablet industry. This cold allergy and sinus tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold allergy and sinus tablet market size has grown strongly in recent years. It will grow from $29.00 billion in 2024 to $30.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the increasing prevalence of seasonal allergies, a rise in over-the-counter (OTC) medication sales, greater awareness of allergy symptoms, a rise in sinus infections, and improved healthcare access in developing countries.

The cold allergy and sinus tablet market size is expected to see strong growth in the next few years. It will grow to $37.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. Growth during the forecast period is expected to be driven by higher levels of air pollution, increased urbanization, a growing elderly population, rising demand for non-drowsy formulations, and an uptick in respiratory illnesses. Key trends anticipated for the forecast period include a shift toward natural and herbal remedies, a growing preference for combination therapies, personalized allergy treatments, innovations in nasal drug delivery systems, and an emphasis on pediatric-friendly formulations.

The increasing incidence of allergies and respiratory disorders is projected to drive growth in the cold allergy and sinus tablet market in the years ahead. These conditions involve immune system responses to allergens and affect the respiratory system, leading to illnesses such as asthma and allergic rhinitis. The surge in allergies and respiratory issues is largely linked to rising air pollution, which heightens exposure to allergens and airborne irritants that trigger adverse immune and respiratory reactions. Cold allergy and sinus tablets assist in managing these conditions by providing effective symptom relief, thereby enhancing the quality of life for individuals suffering from colds, sinus infections, and allergic reactions. For example, in September 2023, the World Health Organization, an intergovernmental agency based in Switzerland, reported that chronic respiratory diseases were responsible for 4.1 million deaths, ranking behind cardiovascular disease (17.9 million deaths) and cancer (9.3 million deaths), and ahead of diabetes (2.0 million deaths). Thus, the rising prevalence of respiratory and allergic conditions is fueling demand in the cold allergy and sinus tablet market.

Key players in the cold allergy and sinus tablet sector are investing in advanced drug formulations, such as extended-release tablets, to provide prolonged symptom relief and greater convenience for users. Extended-release tablets are designed to gradually deliver medication over an extended timeframe, ensuring sustained therapeutic effects. For instance, in July 2022, Dr. Reddy's Laboratories Ltd., a pharmaceutical firm based in India, launched an over-the-counter (OTC) store-brand version of Allegra-D 24 HR in the United States. This formulation combines 180 mg of Fexofenadine HCl with 240 mg of Pseudoephedrine HCl in an extended-release format, offering 24-hour relief from sinus pressure, nasal congestion, and sneezing. The product delivers a cost-effective, non-drowsy alternative for managing symptoms associated with seasonal allergic rhinitis and similar conditions.

In June 2022, Glenmark Pharmaceuticals Ltd., an India-based drug manufacturer, acquired approved generic versions of several OTC medications from Wockhardt Ltd. for an undisclosed sum. This move was intended to strengthen Glenmark's foothold in the U.S. OTC market by broadening its range of approved generic offerings, enhancing its market presence, and improving access for consumers. Wockhardt Ltd. is also based in India and produces a variety of cold, allergy, and sinus treatment products.

The increasing incidence of allergies and respiratory disorders is projected to drive growth in the cold allergy and sinus tablet market in the years ahead. These conditions involve immune system responses to allergens and affect the respiratory system, leading to illnesses such as asthma and allergic rhinitis. The surge in allergies and respiratory issues is largely linked to rising air pollution, which heightens exposure to allergens and airborne irritants that trigger adverse immune and respiratory reactions. Cold allergy and sinus tablets assist in managing these conditions by providing effective symptom relief, thereby enhancing the quality of life for individuals suffering from colds, sinus infections, and allergic reactions. For example, in September 2023, the World Health Organization, an intergovernmental agency based in Switzerland, reported that chronic respiratory diseases were responsible for 4.1 million deaths, ranking behind cardiovascular disease (17.9 million deaths) and cancer (9.3 million deaths), and ahead of diabetes (2.0 million deaths). Thus, the rising prevalence of respiratory and allergic conditions is fueling demand in the cold allergy and sinus tablet market.

Key players in the cold allergy and sinus tablet sector are investing in advanced drug formulations, such as extended-release tablets, to provide prolonged symptom relief and greater convenience for users. Extended-release tablets are designed to gradually deliver medication over an extended timeframe, ensuring sustained therapeutic effects. For instance, in July 2022, Dr. Reddy's Laboratories Ltd., a pharmaceutical firm based in India, launched an over-the-counter (OTC) store-brand version of Allegra-D 24 HR in the United States. This formulation combines 180 mg of Fexofenadine HCl with 240 mg of Pseudoephedrine HCl in an extended-release format, offering 24-hour relief from sinus pressure, nasal congestion, and sneezing. The product delivers a cost-effective, non-drowsy alternative for managing symptoms associated with seasonal allergic rhinitis and similar conditions.

In June 2022, Glenmark Pharmaceuticals Ltd., an India-based drug manufacturer, acquired approved generic versions of several OTC medications from Wockhardt Ltd. for an undisclosed sum. This move was intended to strengthen Glenmark's foothold in the U.S. OTC market by broadening its range of approved generic offerings, enhancing its market presence, and improving access for consumers. Wockhardt Ltd. is also based in India and produces a variety of cold, allergy, and sinus treatment products.

Major players in the cold allergy and sinus tablet market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc. , Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz Group AG, Alcon Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals plc, Lupin Ltd., Glenmark Pharmaceuticals Ltd., LETI Pharma GmbH.

North America was the largest region in the cold allergy and sinus tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold allergy and sinus tablet report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold allergy and sinus tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold allergy and sinus tablet market consists of sales of allerhin cold tablet, sinarest tablet, and allergix cold care tablet. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold Allergy And Sinus Tablet Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold allergy and sinus tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cold allergy and sinus tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold allergy and sinus tablet market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Antihistamines; Decongestants; Cough Suppressants; Expectorants; Combination Tablets
  • 2) By Formulation Type: Tablets; Capsules; Liquids; Effervescent Tablets; Powders
  • 3) By Consumer Age Group: Children (0-12 years); Teenagers (13-19 years); Adults (20-64 years); Seniors (65 years and above)
  • 4) By Application Area: Allergic Rhinitis; Common Cold; Sinusitis; Other Respiratory Conditions
  • 5) By Distribution Channel: Pharmacies; Online Stores; Supermarkets Or Hypermarkets; Other Distribution Channels
  • Subsegments:
  • 1) By Antihistamines: Loratadine; Cetirizine; Fexofenadine; Diphenhydramine; Chlorpheniramine
  • 2) By Decongestants: Pseudoephedrine; Phenylephrine; Oxymetazoline
  • 3) By Cough Suppressants: Dextromethorphan; Codeine; Benzonatate
  • 4) By Expectorants: Guaifenesin; Ammonium Chloride
  • 5) By Combination Tablets: Antihistamine-Decongestant Combos; Antihistamine-Cough Suppressant Combos; Multi-Symptom Cold And Flu Tablets
  • Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cold Allergy And Sinus Tablet Market Characteristics

3. Cold Allergy And Sinus Tablet Market Trends And Strategies

4. Cold Allergy And Sinus Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold Allergy And Sinus Tablet Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cold Allergy And Sinus Tablet PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cold Allergy And Sinus Tablet Market Growth Rate Analysis
  • 5.4. Global Cold Allergy And Sinus Tablet Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cold Allergy And Sinus Tablet Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cold Allergy And Sinus Tablet Total Addressable Market (TAM)

6. Cold Allergy And Sinus Tablet Market Segmentation

  • 6.1. Global Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antihistamines
  • Decongestants
  • Cough Suppressants
  • Expectorants
  • Combination Tablets
  • 6.2. Global Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Capsules
  • Liquids
  • Effervescent Tablets
  • Powders
  • 6.3. Global Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Children (0-12 years)
  • Teenagers (13-19 years)
  • Adults (20-64 years)
  • Seniors (65 years and above)
  • 6.4. Global Cold Allergy And Sinus Tablet Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allergic Rhinitis
  • Common Cold
  • Sinusitis
  • Other Respiratory Conditions
  • 6.5. Global Cold Allergy And Sinus Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacies
  • Online Stores
  • Supermarkets Or Hypermarkets
  • Other Distribution Channels
  • 6.6. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Loratadine
  • Cetirizine
  • Fexofenadine
  • Diphenhydramine
  • Chlorpheniramine
  • 6.7. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pseudoephedrine
  • Phenylephrine
  • Oxymetazoline
  • 6.8. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Cough Suppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dextromethorphan
  • Codeine
  • Benzonatate
  • 6.9. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guaifenesin
  • Ammonium Chloride
  • 6.10. Global Cold Allergy And Sinus Tablet Market, Sub-Segmentation Of Combination Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antihistamine-Decongestant Combos
  • Antihistamine-Cough Suppressant Combos
  • Multi-Symptom Cold And Flu Tablets

7. Cold Allergy And Sinus Tablet Market Regional And Country Analysis

  • 7.1. Global Cold Allergy And Sinus Tablet Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cold Allergy And Sinus Tablet Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cold Allergy And Sinus Tablet Market

  • 8.1. Asia-Pacific Cold Allergy And Sinus Tablet Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cold Allergy And Sinus Tablet Market

  • 9.1. China Cold Allergy And Sinus Tablet Market Overview
  • 9.2. China Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cold Allergy And Sinus Tablet Market

  • 10.1. India Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cold Allergy And Sinus Tablet Market

  • 11.1. Japan Cold Allergy And Sinus Tablet Market Overview
  • 11.2. Japan Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cold Allergy And Sinus Tablet Market

  • 12.1. Australia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cold Allergy And Sinus Tablet Market

  • 13.1. Indonesia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cold Allergy And Sinus Tablet Market

  • 14.1. South Korea Cold Allergy And Sinus Tablet Market Overview
  • 14.2. South Korea Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cold Allergy And Sinus Tablet Market

  • 15.1. Western Europe Cold Allergy And Sinus Tablet Market Overview
  • 15.2. Western Europe Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cold Allergy And Sinus Tablet Market

  • 16.1. UK Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cold Allergy And Sinus Tablet Market

  • 17.1. Germany Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cold Allergy And Sinus Tablet Market

  • 18.1. France Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cold Allergy And Sinus Tablet Market

  • 19.1. Italy Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cold Allergy And Sinus Tablet Market

  • 20.1. Spain Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cold Allergy And Sinus Tablet Market

  • 21.1. Eastern Europe Cold Allergy And Sinus Tablet Market Overview
  • 21.2. Eastern Europe Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cold Allergy And Sinus Tablet Market

  • 22.1. Russia Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cold Allergy And Sinus Tablet Market

  • 23.1. North America Cold Allergy And Sinus Tablet Market Overview
  • 23.2. North America Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cold Allergy And Sinus Tablet Market

  • 24.1. USA Cold Allergy And Sinus Tablet Market Overview
  • 24.2. USA Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cold Allergy And Sinus Tablet Market

  • 25.1. Canada Cold Allergy And Sinus Tablet Market Overview
  • 25.2. Canada Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cold Allergy And Sinus Tablet Market

  • 26.1. South America Cold Allergy And Sinus Tablet Market Overview
  • 26.2. South America Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cold Allergy And Sinus Tablet Market

  • 27.1. Brazil Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cold Allergy And Sinus Tablet Market

  • 28.1. Middle East Cold Allergy And Sinus Tablet Market Overview
  • 28.2. Middle East Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cold Allergy And Sinus Tablet Market

  • 29.1. Africa Cold Allergy And Sinus Tablet Market Overview
  • 29.2. Africa Cold Allergy And Sinus Tablet Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cold Allergy And Sinus Tablet Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cold Allergy And Sinus Tablet Market, Segmentation By Consumer Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cold Allergy And Sinus Tablet Market Competitive Landscape And Company Profiles

  • 30.1. Cold Allergy And Sinus Tablet Market Competitive Landscape
  • 30.2. Cold Allergy And Sinus Tablet Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Cold Allergy And Sinus Tablet Market Other Major And Innovative Companies

  • 31.1. Takeda Pharmaceutical Company Limited
  • 31.2. GlaxoSmithKline plc
  • 31.3. Reckitt Benckiser Group plc
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Mylan N.V.
  • 31.6. Sandoz Group AG
  • 31.7. Alcon Inc.
  • 31.8. Sun Pharmaceutical Industries Ltd.
  • 31.9. Perrigo Company plc
  • 31.10. Dr. Reddy's Laboratories
  • 31.11. Cipla Limited
  • 31.12. Hikma Pharmaceuticals plc
  • 31.13. Lupin Ltd.
  • 31.14. Glenmark Pharmaceuticals Ltd.
  • 31.15. LETI Pharma GmbH

32. Global Cold Allergy And Sinus Tablet Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold Allergy And Sinus Tablet Market

34. Recent Developments In The Cold Allergy And Sinus Tablet Market

35. Cold Allergy And Sinus Tablet Market High Potential Countries, Segments and Strategies

  • 35.1 Cold Allergy And Sinus Tablet Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cold Allergy And Sinus Tablet Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cold Allergy And Sinus Tablet Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer